Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28258836 | 1.00 | AKR1B1 (0.39) | AKR1B1LMNAL3MBTL1TDP1 | |
| SCHEMBL3239490 | 0.80 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL680091 | 0.80 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL26929232 | 0.80 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL7641965 | 0.80 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL2635171 | 0.78 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL458624 | 0.78 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL10713443 | 0.78 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL8857027 | 0.78 | AKR1B1 (0.36) | AKR1B1 | |
| SCHEMBL309710 | 0.78 | AKR1B1 (0.36) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851455-B2 | Acidic dystroglycan oligosaccharide compound and method for making same | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-12-26 | — | — | US | disclosed |
| EP-4289958-A1 | PROTEIN HAVING 1,3-FUCOSYLTRANSFERASE ACTIVITY, AND METHOD FOR PRODUCING FUCOSE-CONTAINING SUGAR | Kyowa Hakko Bio Co., Ltd. (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-116806260-A | Method for producing protein having 1, 3-fucosyltransferase activity and fucose-containing saccharide | 协和发酵生化株式会社 | 2023-09-26 | — | — | CN | disclosed |
| WO-2019136399-A1 | ACIDIC DYSTROGLYCAN OLIGOSACCHARIDE COMPOUND AND METHOD FOR MAKING SAME | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-07-11 | — | — | WO | disclosed |
| WO-2012067614-A1 | PERIODONTITIS TREATMENT | KADOR PETER F (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2012067614-A1 | PERIODONTITIS TREATMENT | KADOR PETER F (US) | 2012-05-24 | — | — | WO | disclosed |
| US-20100292287-A1 | Periodontitis treatment | KADOR PETER F | 2010-11-18 | — | — | US | disclosed |
| US-20100292287-A1 | Periodontitis treatment | KADOR PETER F | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851455-B2 | Acidic dystroglycan oligosaccharide compound and method for making same | OGA, CSGALNACT1, B3GAT3 | AKR1B1 3930/4885LMNA 844/4885L3MBTL1 1219/4885 |
| US-20100292287-A1 | Periodontitis treatment | LCT, NNT, APRT | AKR1B1 15/4885LMNA 3492/4885L3MBTL1 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.